We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Technique Detects Down Syndrome in Fetuses in Two Hours

By Biotechdaily staff writers
Posted on 27 Aug 2007
A new technique enables pregnant women to know whether their fetus has Down syndrome in just a few hours.

Called FlashFISH, the new technique is a modification of the existing standard fluorescence in situ hybridization (FISH) test, which provides results in 24-48 hours. More...
Another procedure, called karyotyping, delivers results between eight and 21 days.

Both FlashFISH and the standard FISH involve inserting a needle through the pregnant woman's abdominal wall to draw amniotic fluid from the womb. The amniotic fluid comes from the membranous sac, which surrounds the embryo and contains genetic material from the fetus. The FlashFISH test requires only two ml of fluid compared with 5 ml needed for standard tests. Clinicians examine fetal cells in the fluid by maneuvering a molecular probe directly into the cells' nucleus. The probe is a tiny portion of DNA that can attach to a matching sequence in the fetal cell and identify whether it is abnormal.

The new procedure was developed by assistant Prof. Mahesh Choolani, from the department of obstetrics and gynecology, National University of Singapore (NUS; Singapore), and his laboratory team. Dr Choolani reported that FlashFISH matches the accuracy of the currently used standard FISH test. He added that it poses no additional risks to the mother and costs roughly the same amount as the currently used test.

Prof. Choolani said that the test has proved to be 99% accurate in detecting Down syndrome. The new technique carries the same risk of miscarriage--about one in 100--as the traditional tests because it involves inserting a needle into the womb.

The test particularly will be useful for women who become pregnant after age 35 because they are more at risk for having a child with Down syndrome. Prof. Choolani said that they had decided to develop a faster test because, Waiting for test results can cause a lot of anxiety in couples.


Related Links:
National University of Singapore

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.